1035895-89-6

Basic information

• Product Name: ent-OseltaMivir Phosphate
• Synonyms: ent-OseltaMivir Phosphate;(3S,4S,5R)-4-(AcetylaMino)-5-aMino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid Ethyl Ester Phosphate
• CAS NO: 1035895-89-6
• Molecular Formula: C16H29N2O8P
• Molecular Weight: 408.383821
• Product Categories: Amines;Anti-virals;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 1035895-89-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ent-OseltaMivir Phosphate(CAS DataBase Reference)
• NIST Chemistry Reference: ent-OseltaMivir Phosphate(1035895-89-6)
• EPA Substance Registry System: ent-OseltaMivir Phosphate(1035895-89-6)

Safety Data

• Hazardous Substances Data: 1035895-89-6(Hazardous Substances Data)

Usage

Description

ent-OseltaMivir Phosphate is the enantiomer of the influenza neuraminidase inhibitor prodrug Oseltamivir Phosphate (O701010). It is a chiral molecule that has a specific three-dimensional arrangement of atoms, which makes it a unique compound with distinct properties compared to its mirror-image counterpart. As a COVID-19 related research product, ent-OseltaMivir Phosphate has gained significant attention for its potential applications in the field of antiviral research and drug development.

Uses

Used in Pharmaceutical Industry:
ent-OseltaMivir Phosphate is used as an antiviral agent for the research and development of treatments targeting influenza viruses. Its unique structure allows it to inhibit the neuraminidase enzyme, which is essential for the replication and spread of the virus within the host. This inhibition helps to reduce the severity and duration of influenza symptoms, as well as the transmission of the virus to others.
Used in COVID-19 Research:
In the context of the COVID-19 pandemic, ent-OseltaMivir Phosphate is used as a research compound to explore its potential efficacy against the SARS-CoV-2 virus. Given its mechanism of action as a neuraminidase inhibitor, it may offer insights into the development of new antiviral therapies or the repurposing of existing drugs to combat COVID-19.
Used in Drug Development:
ent-OseltaMivir Phosphate is also used in the development of new drugs and therapies for various viral infections. Its unique structure and mechanism of action provide a valuable starting point for the design and synthesis of novel antiviral agents. Researchers can use this compound to study its interactions with viral proteins and develop new strategies for inhibiting viral replication and spread.